祥生医疗前三季度净利9392.05万元，同比下降4.56%

Core Viewpoint - Xiangsheng Medical (688358) reported a decline in both revenue and net profit for the first three quarters of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved approximately 343 million yuan in revenue for the first three quarters, representing a year-on-year decrease of 5.27% [1] - The net profit attributable to shareholders was about 93.92 million yuan, reflecting a year-on-year decline of 4.56% [1]